Robert Ford Joins CoreStack as VP of Enterprise Strategy
The Renowned Ex-Microsoft IT Executive, CIO, and Digital Transformation Expert to Support CoreStack’s Continued Growth…
The Renowned Ex-Microsoft IT Executive, CIO, and Digital Transformation Expert to Support CoreStack’s Continued Growth…
The first contact center solution purpose-built for the healthcare industry wins recognition for helping reimagine…
ALEXANDRIA, Va.–(BUSINESS WIRE)–#hybridcloud–greymatter.io a microservices platform meeting the complex hybrid, multi-cloud, and on-prem needs of…
Accomplished business executive to lead Cubic’s financial growth and transformation SAN DIEGO–(BUSINESS WIRE)–Cubic Corporation today…
Goodbye Carrier Hype. Hello Real Results. Goodbye One-Size-Fits-All. Hello Flexibility. T-Mobile 5G Advanced Network Solutions…
Announced at National Digestive Disease Week, Micro-Tech is the only GI endoscopy distributor of the…
By Kevin Peterson, Senior Cybersecurity Strategist, Xalient Remote and hybrid working patterns have extended the…
EDMONTON, Alberta, May 23, 2022 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”…
BOSTON, May 23, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Top-line data anticipated in the Q3 2022 SAN DIEGO, May 23, 2022 (GLOBE NEWSWIRE) —…
VANCOUVER, Washington, May 23, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today…
SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM),…
SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
– Six abstracts presented highlighting data on BylvayTM(odevixibat) and effects on pruritus, serum bile acids,…
Phase 1b/2 combination study, FIRELIGHT-1, to leverage insights from pediatric development to evaluate potential synergistic…
Innoviva to acquire all outstanding shares of Entasis it does not already own for $2.20…
Quoin obtains option to exclusive global rights to product; no upfront or milestone fees ASHBURN,…
The partnership will evaluate Lupagen’s extracorporeal in vivo delivery technology as a potential additional route…
NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…